Skip to main content
SCNIR
Severe Chronic Neutropenia International Registry
Show Navigation
Hide Navigation
Home
About Us
Research laboratory
Genetic Testing
Data Protection
Team
COVID-19
Neutropenia
Handbooks
Forms
Consents
Registration Forms
Yearly Follow-up
Special Events
Laboratory Diagnostics
Publications
Book contributions
Manuscripts
Links
Partners
Armenia
Austria
Belgium
Croatia
Czech Republic
Denmark
Egypt
Estonia
Finland
Germany
Greece
Iran
Ireland
Israel
Italy
Norway
Poland
Portugal
Romania
Russia
Slovakia
Spain
Sweden
Switzerland
The Netherlands
Turkey
UK
Contact us
Leukemia
Update on the G-CSF receptor gene mutations in patients with severe congenital neutropenia (CN)
Germeshausen M, Jakobs S, Zeidler C, Welte K. (2001). Blood 98(11):441a (abstract #1847)
Leukemia
Mutations of the G-CSF receptor gene in AML secondary to severe congenital neutropenia
Zeidler C, Germeshausen M, Aprikyan AG, Touw I, Dale DC, Welte K (2000). Blood 96(11):501a (abstract #2159)
Leukemia
Morphologic assessment of marrow aspirates in Severe Congenital Neutropenia (CN) fails to predict evolution to myelodysplastic syndrome (MDS) and acute myeloblastic leukemia (AML)
Head DR, Boxer LA, Bolyard AA, Dale DC (1999). Blood 94 (10): 430a
Leukemia
Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia
Tschan CA, Pilz C, Forstmeyer D, Möricke A, Zeidler C, Welte K, Germeshausen M (1999). Blood 94(10):47a (abstract #196
Leukemia
G-CSF receptor mutations in patients with severe congenital neutropenia: Frequency and implications in leukemic development
Germeshausen M, Tidow N, Pilz C Tschan C, Zeidler C, Welte K (1999). Blood 94(10):45a (abstract #188)
Leukemia
G-CSF receptor mutations in patients with severe chronic neutropenia: a step in leukemogenesis?
Welte K, Touw IP for the Severe Chronic Neutropenia International Registry (1997). Blood 90:433a
Leukemia
MDS/AML in patients with severe chronic neutropenia (SCN) receiving G-CSF
Freedman MH, Bonilla MA, Boxer L, Catalano P, Cham B, Fier C, Kannourakis G, Kinsey S, Mori PG, Shannon K, Touw I, Welte K, Dale DC, for the Severe Chronic Neutropenia International Registry (1996). Blood 88:448a
Leukemia
Development of AML/MDS in a subset of patients (PTS) with severe chronic neutropenia (SCN)
Dale DC, Bonilla MA, Boxer L, Freedman M, Brown S, Fier C, Welte K. (1994). Blood 84:518a
Leukemia
Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia (CN) treated with recombinant human granulocyte colony stimulating factor (rh-G-CSF)
Kalra R, Dale D, Freedman M, Bonilla MA, Weinblatt M, Ganser A, Bowman P, Abish S, Priest J, Olson K, Paderanga D, Shannon K (1994). Blood 84(10): 313a
Leukemia
Scroll to the top